BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15691066)

  • 1. Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
    Padi SS; Kulkarni SK
    Indian J Exp Biol; 2005 Jan; 43(1):53-60. PubMed ID: 15691066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
    Padi SS; Jain NK; Singh S; Kulkarni SK
    Eur J Pharmacol; 2004 Apr; 491(1):69-76. PubMed ID: 15102535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia.
    Satyanarayana PS; Jain NK; Singh S; Kulkarni SK
    Inflammopharmacology; 2004; 12(1):57-68. PubMed ID: 15035779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
    Lee IO; Seo Y
    Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential effects of acetaminophen on lipopolysaccharide induced hyperalgesia in various mouse pain models.
    Seo YJ; Kwon MS; Choi HW; Choi SM; Nam JS; Lee JK; Jung JS; Park SH; Suh HW
    Pharmacol Biochem Behav; 2008 Nov; 91(1):121-7. PubMed ID: 18639580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective dose of valdecoxib in experimental mouse models of pain.
    Guo CX; Irwin MG; Cheung KM; Chan D
    Methods Find Exp Clin Pharmacol; 2007; 29(6):383-8. PubMed ID: 17922065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide.
    Ganey PE; Barton YW; Kinser S; Sneed RA; Barton CC; Roth RA
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):113-21. PubMed ID: 11446826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats.
    Ahn DK; Chae JM; Choi HS; Kyung HM; Kwon OW; Park HS; Youn DH; Bae YC
    Pain; 2005 Sep; 117(1-2):204-13. PubMed ID: 16098663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.
    Narita M; Shimamura M; Imai S; Kubota C; Yajima Y; Takagi T; Shiokawa M; Inoue T; Suzuki M; Suzuki T
    Neuroscience; 2008 Mar; 152(2):477-86. PubMed ID: 18262365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans.
    Koppert W; Wehrfritz A; Körber N; Sittl R; Albrecht S; Schüttler J; Schmelz M
    Pain; 2004 Mar; 108(1-2):148-53. PubMed ID: 15109518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
    Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
    Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
    Zhang YH; Lu J; Elmquist JK; Saper CB
    J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test.
    Tassorelli C; Greco R; Wang D; Sandrini G; Nappi G
    Eur J Pharmacol; 2006 Mar; 534(1-3):103-7. PubMed ID: 16507304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat.
    Kawakami M; Matsumoto T; Hashizume H; Kuribayashi K; Tamaki T
    J Orthop Res; 2002 Mar; 20(2):376-81. PubMed ID: 11918320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats.
    Veiga AP; Duarte ID; Avila MN; da Motta PG; Tatsuo MA; Francischi JN
    Life Sci; 2004 Oct; 75(23):2807-17. PubMed ID: 15464832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tumor necrosis factor, interleukin-6 and cyclooxygenase pathway with lipopolysaccharide-induced intussusception.
    Sönmez K; Karabulut R; Türkyilmaz Z; Demiroğullari B; Ozen IO; Gülen S; Başaklar AC; Kale N
    Eur J Pediatr Surg; 2008 Apr; 18(2):103-6. PubMed ID: 18437654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes.
    Dhir A; Naidu PS; Kulkarni SK
    Addict Biol; 2005 Dec; 10(4):329-35. PubMed ID: 16318954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.
    Zhang Y; Shaffer A; Portanova J; Seibert K; Isakson PC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1069-75. PubMed ID: 9399978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats.
    Matsunaga A; Kawamoto M; Shiraishi S; Yasuda T; Kajiyama S; Kurita S; Yuge O
    Eur J Pharmacol; 2007 Jan; 554(1):12-7. PubMed ID: 17112505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.